Tumour budding is a reproducible index for risk stratification of patients with <scp>S</scp>tage <scp>II</scp> colon cancer

Abstract

Tumour budding is a strong and reproducible prognostic factor for adverse outcome in Stage II colon cancer, which may serve as a prognostic marker to identify patients with a high risk of recurrence who may benefit from adjuvant therapy.